Current liabilities increased 38.5%
Current liabilities changed +38.5% from the comparable as-filed period.
$926.6M→$1.3B3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →STE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 72.4%
Cash & equivalents changed +72.4% from the comparable as-filed period.
$279.7M→$482.3M0 prior comparisons
Free-cash-flow proxy decreased 14.3%
Free-cash-flow proxy changed -14.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$326.4M→$279.6M2 prior comparisons
Operating income increased 16.2%
Operating income changed +16.2% from the comparable as-filed period.
$246.0M→$285.8M2 prior comparisons
Shares outstanding decreased 1.0%
Shares outstanding changed -1.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
98,490,606→97,500,1108 prior comparisons
Operating margin moved 146 bp higher
Operating margin changed +146 basis points from the comparable as-filed period.
17.68%→19.15%2 prior comparisons
Operating cash flow decreased 12.6%
Operating cash flow changed -12.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$420.0M→$367.1M2 prior comparisons
Net debt decreased 28.1%
Net debt changed -28.1% from the comparable as-filed period.
$1.6B→$1.2B0 prior comparisons
Free-cash-flow margin moved 473 bp lower
Free-cash-flow margin changed -473 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
23.46%→18.73%2 prior comparisons
Operating cash-flow margin moved 560 bp lower
Operating cash-flow margin changed -560 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
30.19%→24.59%2 prior comparisons
Debt / equity moved 446 bp lower
Debt / equity changed -446 basis points from the comparable as-filed period.
27.36%→22.90%2 prior comparisons
Debt / revenue moved 2625 bp lower
Debt / revenue changed -2625 basis points from the comparable as-filed period.
136.81%→110.55%2 prior comparisons
Debt / assets moved 292 bp lower
Debt / assets changed -292 basis points from the comparable as-filed period.
18.29%→15.37%3 prior comparisons
Revenue increased 7.3%
Revenue changed +7.3% from the comparable as-filed period.
$1.4B→$1.5B2 prior comparisons
Gross margin moved 69 bp higher
Gross margin changed +69 basis points from the comparable as-filed period.
45.14%→45.84%2 prior comparisons
Inventory / revenue moved 161 bp higher
Inventory / revenue changed +161 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
46.09%→47.71%2 prior comparisons
Net income increased 12.8%
Net income changed +12.8% from the comparable as-filed period.
$177.4M→$200.1M2 prior comparisons
Current assets increased 18.9%
Current assets changed +18.9% from the comparable as-filed period.
$2.1B→$2.4B3 prior comparisons
Noncurrent long-term debt decreased 13.3%
Noncurrent long-term debt changed -13.3% from the comparable as-filed period.
$1.9B→$1.7B3 prior comparisons
Gross debt decreased 13.3%
Gross debt changed -13.3% from the comparable as-filed period.
$1.9B→$1.7B3 prior comparisons
Reported total debt decreased 13.3%
Reported total debt changed -13.3% from the comparable as-filed period.
$1.9B→$1.7B3 prior comparisons
Cash / debt moved 1453 bp higher
Cash / debt changed +1453 basis points from the comparable as-filed period.
14.70%→29.23%0 prior comparisons
Operating cash flow / net income decreased 22.5%
Operating cash flow / net income changed -22.5% from the comparable as-filed period.
2.37→1.832 prior comparisons
Capex / revenue moved 87 bp lower
Capex / revenue changed -87 basis points from the comparable as-filed period.
6.73%→5.86%2 prior comparisons
Stockholders' equity increased 3.6%
Stockholders' equity changed +3.6% from the comparable as-filed period.
$7.0B→$7.2B2 prior comparisons
Short-term borrowings changed across a zero base
Short-term borrowings changed from 0 to 243400000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$243.4M3 prior comparisons
Research & development increased 8.3%
Research & development changed +8.3% from the comparable as-filed period.
$26.4M→$28.6M2 prior comparisons
Gross profit increased 8.9%
Gross profit changed +8.9% from the comparable as-filed period.
$628.0M→$684.2M2 prior comparisons
Inventory increased 11.1%
Inventory changed +11.1% from the comparable as-filed period.
$641.2M→$712.1M3 prior comparisons
Trade receivables increased 7.0%
Trade receivables changed +7.0% from the comparable as-filed period.
$947.1M→$1.0B3 prior comparisons
Total assets increased 3.2%
Total assets changed +3.2% from the comparable as-filed period.
$10.4B→$10.7B3 prior comparisons
SBC / revenue moved 0 bp higher
SBC / revenue changed +0 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.86%→0.86%2 prior comparisons
Cost of revenue increased 6.0%
Cost of revenue changed +6.0% from the comparable as-filed period.
$763.1M→$808.6M2 prior comparisons
Selling, general & administrative increased 4.5%
Selling, general & administrative changed +4.5% from the comparable as-filed period.
$353.8M→$369.7M2 prior comparisons
Current ratio decreased 14.2%
Current ratio changed -14.2% from the comparable as-filed period.
2.22→1.913 prior comparisons
Stock-based compensation increased 7.6%
Stock-based compensation changed +7.6% from the comparable as-filed period.
$11.9M→$12.8M2 prior comparisons
Working capital increased 2.8%
Working capital changed +2.8% from the comparable as-filed period.
$1.1B→$1.2B3 prior comparisons
Capital expenditure decreased 6.5%
Capital expenditure changed -6.5% from the comparable as-filed period.
$93.6M→$87.5M2 prior comparisons
R&D / revenue moved 2 bp higher
R&D / revenue changed +2 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.90%→1.92%2 prior comparisons
Receivables / revenue moved 21 bp lower
Receivables / revenue changed -21 basis points from the comparable as-filed period.
68.08%→67.88%2 prior comparisons
Working capital / assets moved 4 bp lower
Working capital / assets changed -4 basis points from the comparable as-filed period.
10.87%→10.83%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.